NCT01548417View on ClinicalTrials.gov

Medication Development in Alcoholism: Investigating Glucocorticoid Antagonists

PHASE2CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Alcoholism
Interventions
DRUG

Korlym (mifepristone)

600 mg/day, oral pill, 7 days

DRUG

Sugar Pill

600 mg/day, oral pill, 7 days

Trial Locations (1)

92037

The Scripps Research Institute, La Jolla

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

The Scripps Research Institute

OTHER

NCT01548417 - Medication Development in Alcoholism: Investigating Glucocorticoid Antagonists | Biotech Hunter | Biotech Hunter